Laboratory Evaluation for Nausea, Vomiting, and Epigastric Pain
For patients presenting with nausea, vomiting, and epigastric pain, a comprehensive laboratory panel should include complete blood count (CBC), comprehensive metabolic panel (CMP), lipase, and amylase as first-line tests to evaluate the most common and serious etiologies. 1
First-Line Laboratory Tests
Complete Blood Count (CBC)
- Evaluates for leukocytosis suggesting infection or inflammation
- Assesses for anemia which may indicate GI bleeding
- Helps determine severity of inflammatory conditions
Comprehensive Metabolic Panel (CMP)
- Liver function tests (AST, ALT, bilirubin, alkaline phosphatase)
- Abnormal in 15-30% of various GI conditions 2
- Essential for evaluating hepatobiliary causes of epigastric pain
- Electrolytes and renal function
- Identifies dehydration from vomiting
- Detects acid-base disturbances
- Glucose level
- May be elevated in pancreatitis
- Liver function tests (AST, ALT, bilirubin, alkaline phosphatase)
Lipase
Amylase
Second-Line Laboratory Tests (Based on Clinical Suspicion)
Lipid Panel
- Essential if hypertriglyceridemia-induced pancreatitis is suspected
- Severe hypertriglyceridemia (>1000 mg/dL) can cause pancreatitis with normal amylase/lipase 4
C-Reactive Protein (CRP)
- Best available laboratory marker for severity assessment in pancreatitis
- Peak CRP >210 mg/L in first four days or >150 mg/L at 48 hours indicates severe disease 1
Pregnancy Test
- For women of childbearing age to rule out hyperemesis gravidarum or ectopic pregnancy
Helicobacter pylori Testing
- Consider if peptic ulcer disease is suspected
COVID-19 Testing
- In appropriate epidemiological settings, as GI symptoms may precede respiratory symptoms 2
Diagnostic Algorithm
Initial Evaluation: CBC, CMP, lipase, amylase
- If lipase >3x upper limit: Diagnose acute pancreatitis and proceed with appropriate imaging
- If liver enzymes elevated: Consider hepatobiliary causes and appropriate imaging
- If both normal: Proceed to second-line testing based on clinical suspicion
Second-Line Testing (based on clinical findings and initial results):
- Persistent symptoms with normal initial labs: Consider H. pylori testing, lipid panel
- Signs of infection: Blood cultures, COVID-19 testing if appropriate
- Severe or concerning presentation: Add CRP for prognostication
Important Clinical Considerations
Epigastric pain can have multiple serious etiologies including myocardial infarction, pancreatitis, and acute aortic syndromes that require prompt diagnosis 2
Laboratory tests should be interpreted in conjunction with the timing and nature of pain, relationship to meals, and associated symptoms 2
Normal amylase and lipase do not completely exclude pancreatitis, particularly in cases of hyperlipidemia or chronic pancreatitis 4
Consider atypical presentations of pancreatitis which may present with minimal abdominal symptoms but significant systemic manifestations 5
In patients with abnormal liver enzymes, approximately 15% of COVID-19 patients may have elevated AST/ALT, which should be considered during periods of high prevalence 2
By following this structured laboratory evaluation approach, clinicians can efficiently diagnose the cause of nausea, vomiting, and epigastric pain while minimizing unnecessary testing and delays in treatment.